Clinical Trial Update: Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

View source ↗

Summary

Sponsored by Royal Brompton & Harefield NHS Foundation Trust, this clinical trial investigates whether chest CT biomarkers can predict prognosis in systemic scl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis
• Systemic Sclerosis-associated Interstitial Lung Disease

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Systemic Sclerosis | Status: ENROLLING_BY_INVITATION